(Q34975423)
Statements
Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors (English)
Ferry A L M Eskens
Herman Burger
James P O'Brien
Adelaida Piera
Maja J A de Jonge
Yoshiharu Mizui
Maria Josepa Carreras